Skip to contentR
Rigel Pharmaceuticals Inc
R
RIGLRigel Pharmaceuticals Inc Released Aug 2, 2016, after the close
10-Q filed Aug 2, 2016, 33 days after period end · 0001558370-16-007123
Q2 2016 · 10-Q
Revenue—
Net income—
EPS Diluted-$0.15-$0.15N/M vs Q2 2015N/M vs Q1 2016 No earnings release is on file for this quarter. Its figures came with the 10-Q.
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rigel Pharmaceuticals Inc · CIK 1034842 · Engraved from SEC EDGAR
Operating Income-$13,648,000N/M Operating Cash Flowderived-$18,434,000N/M Free Cash Flowderived-$18,659,000N/M ended Jun 30, 2016 · filed Aug 2, 2016 · 33 d after period end
+22.2% from the close of Aug 2, 2016 to the close of Aug 5, 2016, the first after the release.
after the close$2.52$3.08 Jun 28Aug 2Sep 2